Literature DB >> 33926470

miR-190 promotes malignant transformation and progression of human urothelial cells through CDKN1B/p27 inhibition.

Shirui Huang1, Xiaohui Hua2, Mengjiao Kuang1, Junlan Zhu3, Haiqi Mu1, Zhongxian Tian3, Xiaoqun Zheng3, Qipeng Xie4.   

Abstract

BACKGROUND: Although miR-190 has been reported to be related to human diseases, especially in the development and progression of cancer, its expression in human bladder cancer (BC) and potential contribution to BC remain unexplored.
METHODS: RT-qPCR was used to verify the expression level of miR-190 and CDKN1B. Flow cytometry (FCM) assays were performed to detect cell cycle. Soft agar assay was used to measure anchorage-independent growth ability. Methylation-Specific PCR, Dual-luciferase reporter assay and Western blotting were used to elucidate the potential mechanisms involved.
RESULTS: Our studies revealed that downregulation of the p27 (encoded by CDKN1B gene) protein is an important event related to miR-190, promoting the malignant transformation of bladder epithelial cells. miR-190 binds directly to CDKN1B 3'-UTR and destabilizes CDKN1B mRNA. Moreover, miR-190 downregulates TET1 by binding to the TET1 CDS region, which mediates hypermethylation of the CDKN1B promoter, thereby resulting in the downregulation of CDKN1B mRNA. These two aspects led to miR-190 inhibition of p27 protein expression in human BC cells. A more in-depth mechanistic study showed that c-Jun promotes the transcription of Talin2, the host gene of miR-190, thus upregulating the expression of miR-190 in human BC cells.
CONCLUSIONS: In this study, we found that miR-190 plays an important role in the development of BC. Taken together, these findings indicate that miR-190 may promote the malignant transformation of human urothelial cells by downregulating CDKN1B, which strengthens our understanding of miR-190 in regulating BC cell transformation.

Entities:  

Keywords:  Bladder epithelial cell transformation; CDKN1B; Methylation; TET1; miR-190

Year:  2021        PMID: 33926470     DOI: 10.1186/s12935-021-01937-5

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


  40 in total

1.  miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis.

Authors:  Kevin Beezhold; Jia Liu; Hong Kan; Terry Meighan; Vince Castranova; Xianglin Shi; Fei Chen
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

2.  miR-190 promotes HCC proliferation and metastasis by targeting PHLPP1.

Authors:  Yuzhen Xiong; Shang Wu; Huajun Yu; Jun Wu; Yajun Wang; Huimin Li; Hui Huang; Haitao Zhang
Journal:  Exp Cell Res       Date:  2018-08-06       Impact factor: 3.905

3.  miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.

Authors:  Junko Mukohyama; Taichi Isobe; Qingjiang Hu; Takanori Hayashi; Takashi Watanabe; Masao Maeda; Hisano Yanagi; Xin Qian; Kimihiro Yamashita; Hironobu Minami; Koshi Mimori; Debashis Sahoo; Yoshihiro Kakeji; Akira Suzuki; Piero Dalerba; Yohei Shimono
Journal:  Cancer Res       Date:  2019-08-15       Impact factor: 12.701

4.  Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology.

Authors:  Jeffrey S Damrauer; Katherine A Hoadley; David D Chism; Cheng Fan; Christopher J Tiganelli; Sara E Wobker; Jen Jen Yeh; Matthew I Milowsky; Gopa Iyer; Joel S Parker; William Y Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-11       Impact factor: 11.205

Review 5.  Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.

Authors:  Woonyoung Choi; Bogdan Czerniak; Andrea Ochoa; Xiaoping Su; Arlene Siefker-Radtke; Colin Dinney; David J McConkey
Journal:  Nat Rev Urol       Date:  2014-06-24       Impact factor: 14.432

6.  NF-κB1 p50 promotes p53 protein translation through miR-190 downregulation of PHLPP1.

Authors:  Y Yu; D Zhang; H Huang; J Li; M Zhang; Y Wan; J Gao; C Huang
Journal:  Oncogene       Date:  2013-02-11       Impact factor: 9.867

7.  MicroRNA-190 regulates FOXP2 genes in human gastric cancer.

Authors:  Wen-Zhuo Jia; Tao Yu; Qi An; Hua Yang; Zhu Zhang; Xiao Liu; Gang Xiao
Journal:  Onco Targets Ther       Date:  2016-06-20       Impact factor: 4.147

8.  miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.

Authors:  Yue Yu; Wei Luo; Zheng-Jun Yang; Jiang-Rui Chi; Yun-Rui Li; Yu Ding; Jie Ge; Xin Wang; Xu-Chen Cao
Journal:  Mol Cancer       Date:  2018-03-06       Impact factor: 27.401

9.  Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.

Authors:  Di Jia; Shenglan Li; Dali Li; Haipeng Xue; Dan Yang; Ying Liu
Journal:  Aging (Albany NY)       Date:  2018-04-16       Impact factor: 5.682

10.  miR-190 enhances endocrine therapy sensitivity by regulating SOX9 expression in breast cancer.

Authors:  Yue Yu; Wen Yin; Zhi-Hao Yu; Yan-Jun Zhou; Jiang-Rui Chi; Jie Ge; Xu-Chen Cao
Journal:  J Exp Clin Cancer Res       Date:  2019-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.